{"id":"W4416387758","doi":"10.1016/j.annonc.2025.09.049","title":"LBA3 Pembrolizumab vs placebo plus weekly paclitaxel ± bevacizumab in platinum-resistant recurrent ovarian cancer: Results from the randomized double-blind phase III ENGOT-ov65/KEYNOTE-B96 study","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"Southwest Medical University; University of Science and Technology of China; Tongji Medical College, Huazhong University of Science and Technology; Fourth Military Medical University; Hebei Medical University; Tongji University; Huazhong University of Science and Technology; Chongqing University; Jiangsu Hengrui Medicine","keywords":"Pembrolizumab; Bevacizumab; Placebo; Phases of clinical research; Paclitaxel; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001446965,0.0013411,0.00271467,0.0004495883,0.0003769211,0.001071546,0.0009113546,0.001303895,0.005831946],"category_scores_gemma":[0.001388438,0.0006337605,0.001903497,0.0004887625,0.0009185427,0.001128808,0.000397637,0.003453328,0.001067421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008274174,"about_ca_system_score_gemma":0.0009924879,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00183612,"about_ca_topic_score_gemma":0.003548064,"domain_scores_codex":[0.9995474,0.000229037,0.00002809255,0.00008334725,0.00003540458,0.00007670499],"domain_scores_gemma":[0.9992963,0.0001995234,0.0001818532,0.00005393503,0.00003167129,0.0002366508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9732165,0.003624221,0.0003589579,0.0005371672,0.001026141,0.00001774226,0.00003233021,0.0002997986,0.002306517,0.00006956935,0.0007034412,0.01780758],"study_design_scores_gemma":[0.9445077,0.05067798,0.002355465,0.00004541886,0.0008567303,0.00002597131,0.00002685384,0.0003811963,0.0004262524,0.0001262909,0.0005554168,0.00001478266],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856275,0.007785193,0.0005828479,0.0006821768,0.0005071042,0.001148517,0.00120283,0.000161498,0.002302216],"genre_scores_gemma":[0.9886192,0.003679315,0.0009000711,0.0009078954,0.0003468075,0.00107649,0.001143016,0.00004065286,0.003286604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005831946,"threshold_uncertainty_score":0.01950985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09908739646318673,"score_gpt":0.4280868963601682,"score_spread":0.3289994998969815,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}